healthcarewebsummit bulletin
Click here to view this message in a web browser 
Capital BlueCross Accountable Care Arrangements: A Regional Health Plan's ACO Approach
During the past decade, drug overdose deaths have more than doubled and over 50 percent were related to prescription drugs. Increases in controlled substance prescribing have coincided with higher rates of misuse, abuse, hospitalizations and deaths. Right now, opioids cause more overdose deaths than heroin and cocaine combined.

To address this growing epidemic, Prime Therapeutics LLC has developed a controlled substance (CS) score that identifies high risk CS drug use. Through analysis of the CS score, Prime found a significant association between CS scores and health outcomes (hospitalizations and emergency room visits), CS drug costs, and total cost of care.  The CS score can help health plans identify and intervene with high risk members, and validating the CS score association with health care use and costs helps quantify the potential value of an intervention.

Please join the Prime Therapeutics's Cathy Starner on Thursday, May 21st, 2015 at 1PM Eastern as she reviews the scope of the controlled substance abuse epidemic and a variety of methods to detect misuse and abuse, and then discusses the Prime CS Score study, its implications, and opportunities for stakeholders to lightly manage or aggressively manage the problem; during the Healthcare Web Summit event: Combatting Controlled Substance Abuse. Click here for detailed information and to register or call 209.577.4888.
Past Event CD-Roms
Did you miss a past webinar event? Post-event materials for applicable HealthcareWebSummit events are available for purchase.  Click here for more information and a list of past events.

To review MCOL's Privacy Policy, go to:  
You are receiving this newsletter as a current or former attendee of a Healthcare Web Summit event.
To unsubscribe, please click here
You can also unsubscribe by going directly to:

1101 Standiford Ave., Suite C-3
Modesto, CA 95350